3
Announcements
Trials
Browse
Landscape
Status
Terminated
8
Completed
7
Active not recruiting
4
Unknown
3
Recruiting
2
No longer available
1
Approved for marketing
1
Sponsor Class
OTHER
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Interventions
nilotinib
3
ponatinib
1
Transplantation
1
Bone Marrow Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
ponatinib
×
Clear all
NCT01549548
2013-03-15
Compassionate Use Ponatinib
OHSU Knight Cancer Institute
No longer available